Cordis announces the launch of its Sleek OTW catheter, a new .014” percutaneous transluminal angioplasty balloon catheter designed to help physicians save limbs and enhance patients’ lives. This new balloon was first launched at LINC (Leipzig Interventional Course, Leipzig, Germany) and ISET (International Symposium on Endovascular Therapy, Miami, Florida) earlier this year.
It is estimated that as many as 160,000 lower limbs are amputated every year in the USA due to critical limb ischaemia, and 60–70% of these amputations are performed as the first-line therapy. These lower-limb amputations come with a mortality rate of as much as 70% at five years. Cordis Corporation’s Sleek OTW catheter is the latest technology designed to restore blood flow to the lower limbs, which helps physicians save limbs and enhance patients’ lives.
This catheter has a unique balance of excellent pushability with a small crossing profile that helps physicians reach small arteries below-the-knee and into the foot to restore blood flow to the lower limb. A broad portfolio of sizes is also offered with percutaneous transluminal angioplasty balloon diameters of 1.25mm to 5.0mm and lengths up to 220mm that allow physicians to treat diffuse disease with fewer inflations.
“The Sleek OTW catheter offers our most advanced technology designed to treat challenging below the knee disease,” said Campbell Rogers, chief scientific officer, Global Head R&D. “This addition to our Lower Extremity product portfolio underscores our commitment to providing solutions that help save limbs and improve the quality of life for patients with advanced peripheral vascular disease.”